Related Experiment Video
Updated: Jun 3, 2026
Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Measuring Drug-DNA Adducts in Individual Cells
1Leukaemia Research Fund Laboratory, University of Newcastle Upon Tyne, UK.
Abstract:
Many anticancer drugs and environmental carcinogens exert cytotoxic and or mutagenic effects through the direct reaction with DNA via in the formation of drug-DNA adducts or stabilized protein-DNA complexes (1,2). The ability to determine the extent with which drugs, such as alkylating agents and platinum based drugs, interact with their cellular targets in tumor cells will permit further studies into cytotoxic and biological effects of these drugs. The use of antisera or antibodies directed against specific adducts has facilitated the development of immunologically based assays, such as ELISA methods, to determine the extent of drug-DNA interaction in cells. These techniques however, rely on the measurement of adducts on DNA isolated from millions of cells (described by Tilby in Chapter 12 and refs. 3 and 4).
Insights
Researchers are developing new methods to measure anticancer drug-DNA interactions in tumor cells. This helps understand drug effectiveness and toxicity by detecting drug-DNA adducts using immunological assays.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Anticancer drugs and carcinogens can damage DNA, forming drug-DNA adducts or protein-DNA complexes.
- Understanding drug-DNA interactions is crucial for studying drug efficacy and toxicity in cancer treatment.
Purpose of the Study:
- To explore methods for quantifying drug-DNA interactions within tumor cells.
- To advance the understanding of cytotoxic and biological effects of anticancer drugs.
Main Methods:
- Utilizing antisera and antibodies specific to drug-DNA adducts.
- Developing and applying immunological assays, such as ELISA, for detection.
- Measuring adducts on DNA isolated from cellular samples.
Main Results:
- Immunological assays enable the detection of drug-DNA interactions.
- Current methods require DNA isolation from large cell populations.
Conclusions:
- Immunological assays are valuable tools for assessing drug-DNA interactions.
- Further refinement of techniques is needed to improve sensitivity and reduce sample requirements.
More Related Videos
11:58A Simple, Rapid, and Quantitative Assay to Measure Repair of DNA-protein Crosslinks on Plasmids Transfected into Mammalian Cells
Published on: March 5, 2018
12:15Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter
Published on: May 29, 2019